Abstract |
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) plays a key role in converting intracellular cortisone to physiologically active cortisol, which is implicated in the development of several phenotypes of metabolic syndrome. Inhibition of 11β-HSD1 activity with selective inhibitors has beneficial effects on various conditions, including diabetes, dyslipidemia and obesity, and therefore constitutes a promising strategy to discover novel therapies for metabolic and cardiovascular diseases. A series of novel adamantyl heterocyclic ketones provides potent and selective inhibitors of human 11β-HSD1. Lead compounds display low nanomolar inhibition against human and mouse 11β-HSD1 and are selective with no activity against 11β-HSD2 and 17β-HSD1. Selected potent 11β-HSD1 inhibitors show moderate metabolic stability upon incubation with human liver microsomes and weak inhibition of human CYP450 enzymes.
|
Authors | Xiangdong Su, Nigel Vicker, Mark P Thomas, Fabienne Pradaux-Caggiano, Heather Halem, Michael D Culler, Barry V L Potter |
Journal | ChemMedChem
(ChemMedChem)
Vol. 6
Issue 8
Pg. 1439-51
(Aug 01 2011)
ISSN: 1860-7187 [Electronic] Germany |
PMID | 21608132
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
- Cytochrome P-450 Enzyme Inhibitors
- Enzyme Inhibitors
- Heterocyclic Compounds
- Ketones
- Cytochrome P-450 Enzyme System
- 11-beta-Hydroxysteroid Dehydrogenase Type 1
|
Topics |
- 11-beta-Hydroxysteroid Dehydrogenase Type 1
(antagonists & inhibitors, metabolism)
- Animals
- Binding Sites
- Computer Simulation
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme System
(metabolism)
- Drug Evaluation, Preclinical
- Enzyme Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Heterocyclic Compounds
(chemistry)
- Humans
- Ketones
(chemical synthesis, chemistry, pharmacology)
- Mice
- Microsomes, Liver
(metabolism)
- Structure-Activity Relationship
|